Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Vigil Neuroscience, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −11 vs. Q1 2022
- Shares held
- 17.3M
- −515.0K (−2.9%) vs. Q1 2022
- Total value
- $44.6M
- −$80.5M (−64.4%) vs. Q1 2022
- New holders
- 6
- 6 more added
- Sold out
- 17
- 13 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 2 | $4.55K |
| Q2 2025 | 78 | $265.8M |
| Q1 2025 | 50 | $44.5M |
| Q4 2024 | 51 | $38.4M |
| Q3 2024 | 52 | $94.2M |
| Q2 2024 | 58 | $104.5M |
| Q1 2024 | 54 | $90.5M |
| Q4 2023 | 46 | $84.4M |
| Q3 2023 | 45 | $137.7M |
| Q2 2023 | 47 | $242.1M |
| Q1 2023 | 41 | $245.4M |
| Q4 2022 | 37 | $312.3M |
| Q3 2022 | 33 | $222.7M |
| Q2 2022 | 35 | $44.6M |
| Q1 2022 | 47 | $125.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Vigil Neuroscience, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| New York State Common Retirement Fund | 59 | $0 | 0.00% | −8,441−99.3% | Reduced |
| Wells Fargo & Company | 47 | $0 | 0.00% | −1,418−96.8% | Reduced |
| FMR LLC | 40 | $0 | 0.00% | +40 | New |
| Credit Suisse AG | 4 | $0 | 0.00% | +4 | New |
| JPMorgan Chase & Co | 214 | $1.00K | 0.00% | −2,934−93.2% | Reduced |
| Cubist Systematic Strategies, LLC | 1,118 | $3.00K | 0.00% | +118+11.8% | Added |
| UBS Group AG | 2,448 | $6.00K | 0.00% | +1,528+166.1% | Added |
| Morgan Stanley | 3,338 | $7.00K | 0.00% | +2,462+281.1% | Added |
| Cannell Capital LLC | 3,636 | $9.00K | 0.00% | +3,636 | New |
| Northern Trust Corp | 12,082 | $31.0K | 0.00% | −44,601−78.7% | Reduced |
| Point72 Hong Kong Ltd | 12,139 | $31.0K | 0.00% | −528−4.2% | Reduced |
| State Street Corp | 18,374 | $47.0K | 0.00% | −36,105−66.3% | Reduced |
| Adage Capital Partners GP, L.L.C. | 22,269 | $57.0K | 0.00% | +22,269 | New |
| LMR Partners LLP | 25,337 | $65.0K | 0.00% | −2,305−8.3% | Reduced |
| Renaissance Technologies LLC | 37,488 | $97.0K | 0.00% | +17,447+87.1% | Added |
| Geode Capital Management, LLC | 59,645 | $153.0K | 0.00% | −37,435−38.6% | Reduced |
| Citigroup Inc | 65,063 | $168.0K | 0.00% | +969+1.5% | Added |
| Goldman Sachs Group Inc | 73,077 | $189.0K | 0.00% | −762−1.0% | Reduced |
| DAFNA Capital Management LLC | 99,754 | $257.0K | 0.07% | 00.0% | Unchanged |
| Barclays PLC | 101,681 | $262.0K | 0.00% | −1,092−1.1% | Reduced |
| BlackRock Inc. | 104,223 | $269.0K | 0.00% | −199,466−65.7% | Reduced |
| Laurion Capital Management LP | 130,200 | $336.0K | 0.01% | +130,200 | New |
| Logos Global Management LP | 205,595 | $530.0K | 0.10% | 00.0% | Unchanged |
| Harvard Management Co Inc | 289,460 | $747.0K | 0.09% | 00.0% | Unchanged |
| Deep Track Capital, LP | 308,393 | $796.0K | 0.06% | −80,748−20.8% | Reduced |
| Vanguard Group Inc | 354,208 | $914.0K | 0.00% | −30,990−8.0% | Reduced |
| OrbiMed Advisors LLC | 411,191 | $1.06M | 0.02% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 471,958 | $1.22M | 0.04% | 00.0% | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | 560,595 | $1.45M | 0.73% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 616,786 | $1.59M | 0.12% | 00.0% | Unchanged |
| Artal Group S.A. | 1,121,191 | $2.89M | 0.16% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,165,036 | $5.47M | 0.01% | +2,397+0.1% | Added |
| Northpond Ventures, LLC | 4,214,498 | $10.9M | 10.36% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 5,836,874 | $15.1M | 2.52% | 00.0% | Unchanged |
| PEAK6 Investments LLC | 14,337 | – | – | +14,337 | New |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −86,193−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| Davidson Kempner Capital Management LP | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −19,930−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −19,198−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −13,341−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −3,747−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −3,332−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −2,795−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −2,451−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,773−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −1,519−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −1,600−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,037−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −634−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |